Rufinamide in children and adults with Lennox–Gastaut syndrome: First Italian multicenter experience
Authors:
- Giangennaro CoppolaGCGiangennaro Coppola
- Salvatore GrossoSGSalvatore Grosso
- Emilio FranzoniEFEmilio Franzoni
- Pierangelo VeggiottiPVPierangelo Veggiotti
- Nelia ZamponiNZNelia Zamponi
- Pasquale ParisiPPPasquale Parisi
- Alberto SpaliceASAlberto Spalice
- Francesco HabetswallnerFHFrancesco Habetswallner
- Antonio FelsAFAntonio Fels
- Giuseppe CapovillaGCGiuseppe Capovilla
- Alberto VerrottiAVAlberto Verrotti
- Salvatore ManganoSMSalvatore Mangano
- 1 November 2010
- journal article
- clinical trial
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 19 (9) , 587-591
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension studyActa Neurologica Scandinavica, 2010
- Update on the management of Lennox-Gastaut syndrome with a focus on rufinamideNeuropsychiatric Disease and Treatment, 2009
- Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: A randomized placebo‐controlled trialEpilepsia, 2009
- Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: First European experienceEpilepsy & Behavior, 2009
- The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure modelsEpilepsia, 2008
- Rufinamide for generalized seizures associated with Lennox–Gastaut syndromeNeurology, 2008
- RufinamideNeurotherapeutics, 2007
- Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsyEpilepsy Research, 2001
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989
- Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic SeizuresEpilepsia, 1981